Higher Expression of Activating Receptors on Cytotoxic NK Cells is Associated with Early Control on HIV-1C Multiplication by Archana Gopal Kulkarni et al.
ORIGINAL RESEARCH ARTICLE
published: 16 May 2014
doi: 10.3389/fimmu.2014.00222
Higher expression of activating receptors on cytotoxic NK
cells is associated with early control on HIV-1C
multiplication
Archana Gopal Kulkarni , Ramesh Shivram Paranjape and Madhuri RajeevThakar*
Department of Immunology, National AIDS Research Institute, Pune, India
Edited by:
Annapurna Vyakarnam, King’s College
London, UK
Reviewed by:
Charles Kelly, King’s College London,
UK
Annapurna Vyakarnam, King’s College
London, UK
*Correspondence:
Madhuri RajeevThakar , Department
of Immunology, National AIDS
Research Institute, G-73 MIDC,
Bhosari, Pune 411026, India
e-mail: mthakar@nariindia.org
Natural killer (NK) cells may be important in modulating HIV replication in early course of
HIV infection.The effector function of NK cells is finely tuned by a balance between signals
delivered by activating and inhibitory receptors. However, the influence of expression of
these receptors on the early course of HIV replication and subsequent disease progres-
sion is not explored in the context of HIV-1C infection.The expression pattern of activating
(NKp46, NKp44, NKp30, NKG2D, and NKG2C) and inhibitory (CD158b, NKG2A, and ILT2)
receptors was determined in 20 patients with recent HIV-1C infection within 3–7 months
of acquiring HIV infection and was compared with the expression pattern in individuals
with progressive (N =12), non-progressive HIV-1C infection (LTNPs, N =12) and healthy
seronegative individuals (N =20). The association of the expression of these receptors on
the rate of disease progression was assessed using viral load set point of recently infected
individuals as a marker of disease progression. The study showed that higher cytotoxic
potency of NK cells was associated with low viral load set point in recent HIV infection
(r =−0.701; p=0.0006) and higher CD4 counts (r =0.720; p=0.001). The expression of
activating receptors (NKp46, NKp30, and NKG2D) on cytotoxic NK cells but not on regula-
tory NK cells was also significantly associated with low viral set point (p<0.01) and viral
load in LTNPs and progressors (p<0.01). The study also indicated that cytotoxic NK cells
might show the ability to specifically lyse HIV infected CD4 cells. This data collectively
showed that early and sustained higher expression of activating receptors on cytotoxic
NK cells could be responsible for increased cytotoxicity, reduced viral burden, and thus
delaying the disease progression. The study to identify the molecular mechanism of the
expression of these receptors in HIV infection will be helpful in further understanding of
NK cell mediated control in early HIV infection.
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INTRODUCTION
Early HIV infection is characterized by a dynamic interaction
between the host immune system and the virus. The outcome
of this interaction influences the rate of disease progression. The
important role of innate immune responses in early consequences
of HIV infection has been highlighted recently (1, 2). Natural
killer (NK) cells are crucial mediators of innate immunity and
also promote the development of adaptive immune responses (3,
4). A recent study has shown that women with impaired NK cells
mediated gamma interferon secretion were prone to acquire HIV
infection (5). Increased NK cell activation has been associated with
resistance to HIV-1 infection in a cohort of intra-venous drug
users (6), HIV-discordant couples (7), and perinatally exposed
children born to HIV-1 infected mothers (8). These studies sug-
gest that early NK cell response to HIV might be important in
early control over virus multiplication. A recent RV144 HIV-1
vaccine efficacy trial demonstrated that plasma IgG against the
HIV-1 envelope (env) variable region 1 and 2 inversely correlated
with risk probably due to their ability to promote ADCC thus
further emphasizing probable protective role of NK cells in HIV-1
infection (9).
Natural killer cells express an array of activating and inhibitory
receptors. These receptors provide signals, the balance of which
forms the decision of whether a NK cell becomes activated or the
activation is inhibited (10). Hence, the effector function of NK cells
is finely tuned by a balance between signals delivered by activating
receptors such as NKG2D, natural cytotoxicity receptors (NCRs-
NKp46, NKp44, and NKp30) (3) and inhibitory receptors (for
e.g., CD94-NKG2A) (4). It has been shown that HIV modulates
the expression of various receptors affecting the effector functions
of the NK cells (11, 12). HIV-1 has also been known to reduce the
expression of ligands for NK cell receptors to evade NK cell medi-
ated immune response (13). HIV-1 nef has shown to down regulate
the expression of NKG2D ligands to escape from NK cells mediated
killing (14). Lower expression of NCRs was found to be associated
with decreased cytotoxicity of NK cells in chronic HIV infection
(15). The increased expression of inhibitory receptor, NKG2A on
cytotoxic NK cells have shown to influence the advancement of
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HIV infection through the escape of infected CD4+ T cells (16).
NCR-mediated NK cell activation during HIV infections reported
to have a possible role in the loss of uninfected CD4+ T cells (17).
The role of killer immunoglobulin-like receptors (KIR) on NK
cells such as KIR3DS1/HLABW80I in determining the viral load
set point and protection against opportunistic infection (18, 19),
supports the involvement of NK cells in the control of HIV-1.
However, the influence of expression of activating and
inhibitory receptors is not understood well in early course of HIV-
1C infection. Hence, the present study was planned to understand
the pattern of expression of activating and inhibitory receptors
on NK cells in recent HIV-1 infection and their influence on the
cytotoxic potential of the NK cells and the virus control and HIV
disease progression.
MATERIALS AND METHODS
STUDY POPULATION
From the patients visiting the out-patient clinics of the National
AIDS Research Institute, Pune, India; 20 individuals showing indi-
cation of recent HIV infection (RHI) were enrolled in the study.
The individuals with RHI were identified as the individuals who
had less than 7 months duration between the last HIV-negative test
and first HIV-positive test and gave a recent history of exposure.
These patients were followed up for 2 years at every 3 months.
Additionally, 12 (8 female and 4 male; median age 31). Long
term non-progressors [HIV infected individuals with stable CD4
counts above 500 cells/mm3 and without any history of oppor-
tunistic infection in absence of ART for the last 7 years (20)],
12 patients with CD4 count less than 200 cells/mm3 (henceforth
termed as progressors), and 20 HIV seronegative healthy individu-
als as healthy controls (HC) were also included in the study. Blood
samples collected at the enrollment visit (between 3 and 7 months
of acquiring HIV infection in case of patients with RHI) were
processed for NK cell identification and characterization. For pro-
gressors, the blood samples were collected prior to the initiation
of anti-retroviral treatment. The study was approved by the Ethics
Committee of National AIDS Research Institute and whole blood
samples were obtained after obtaining written informed consent.
In case of recent HIV-1 infection, the mid time point of
the period between last HIV-negative and first HIV-positive test
was considered as tentative date of infection (21). The duration
between the tentative date of infection and date of enrollment was
calculated to get days after infection as described previously.
SAMPLE COLLECTION AND PROCESSING
Twenty milliliters whole blood was collected in EDTA (BD
Biosciences) and peripheral blood mononuclear cells (PBMCs)
were isolated by density gradient centrifugation using Ficoll-
Histopaque 1077 (Sigma-Aldrich, St. Louis, MO, USA) within
6 h of blood collection. The PBMCs were cryopreserved in freez-
ing medium containing 90% fetal calf serum (FCS) and 10%
dimethyl sulfoxide (DMSO) and stored in liquid nitrogen (–
196°C) until further use. The plasma was stored at −70°C within
6 h of collection until further use.
CD4 COUNT AND VIRAL LOAD ESTIMATION
The CD4+ T-cell counts were estimated by flow cytometry
(FACSCalibur, Becton Dickinson, USA) as a part of routine
investigations using TruCOUNT kit (Becton Dickinson, USA).
Plasma viral RNA load was measured by RT PCR (Cobas Amplicor
HIV-1 Monitor Test Kit, version 1.5, Roche Diagnostics, NJ, USA)
according to the manufacturer’s instructions. Lower detection
limit of the plasma viral load assay was 400 RNA copies/ml. Hence
for statistical analysis, values less than 400 RNA copies/ml were
considered to be 400 RNA copies/ml.
The plasma viral load set point (PVL set point) was calcu-
lated in the study participants with RHI as described previously
(22). Depending upon viral load set point, these participants were
grouped into patients with low viral load set point (RHI-LVL)
(PVL set point<4 Log10 copies of RNA/ml) and patients with high
viral load set point (RHI-HVL) (PVL set point>4 Log10 copies of
RNA/ml)(23). Of the 20 participants with RHI, 14 showed VL set
point less than 4 Log10 copies/ml (RHI-LVL) whereas six patients
showed VL set point more than 4 Log10 copies/ml (RHI-HVL).
The demographic, virological, and immunological data of all
study participants is shown in Table 1.
Table 1 | Demographic, virological, and immunological characterization of study participants.
RHI-LVL
(N =14)
RHI-HVL
(N =6)
LTNPS
(N =12)
Progressors
(N =12)
Healthy controls
(N =20)
(Median and range)
Age (years) 28 (16–35) 26 (23–33) 31 (29–34) 38 (27–45) 28 (23–34)
Gender [female (F):
male (M)]
F:12 and M:2 F:4 and M:2 F:8:M:4 F:6:M:5 F:13 and M:7
CD4 count (cells/mm3) 574 (280–1211) 569 (116–743) 695 (476–1069) 111 (26–156) 976 (403–1398)
Time after infection 180 days (75–308) 102 days (25–285) 9 years (8–14) NA NA
VL set point (RNA
copies/ml)
4774 (400–10143) 34957 (13389–228397) NA NA NA
Viral load at enrollment
(RNA copies/ml)
1830 (400–61400) 33950 (16300–55000) 2561 (undetectable–6890) 184137 (18012–482236) NA
Frontiers in Immunology | HIV and AIDS May 2014 | Volume 5 | Article 222 | 2
Kulkarni et al. NK cells in recent HIV-1 infection
MULTI-PARAMETER FLOW CYTOMETRY ANALYSES
The PBMCs cryopreserved at the enrollment visit were revived
and incubated in complete tissue culture medium (RPMI with
10% FCS) in a humidified 5% CO2 incubator overnight. The cells
were stained with monoclonal antibodies (all from BD Biosciences
unless otherwise indicated) to identify NK cells, its subsets, and
to estimate the expression of various activating and inhibitory
receptors on the subsets of NK cells. The peridinin chlorophyll
protein (PerCP)-conjugated anti-CD3, allophycocyanin (APC)
conjugated anti-CD56 and fluorescein isothiocyanate (FITC)-
conjugated anti-CD16 antibodies were used to identify specific NK
cell subsets. Phycoerythrin (PE)-conjugated anti-human antibod-
ies against activating receptors such as NCRs (NKp46, NKp30, and
NKp44), other activating receptors [NKG2C (R&D systems), and
NKG2D], and inhibitory receptors (CD158a, CD158b, NKG2A,
and ILT2) were used to estimate the expression levels of these
receptors. The activation status of the NK cells was analyzed
using PE labeled antibodies against early activation markers;
HLA-DR and CD69. The stained cells were acquired using BD
Cell Quest Pro software and analyzed using FACSCalibur (BD
Biosciences). Using forward and side scatter, the lymphocyte pop-
ulation was gated while acquiring the sample and 50,000 gated
events were acquired (Figure 1A). The NK cell population was
then identified as (CD3−CD16+ and/or CD56+) cells (Figure 1B)
and further categorized into different NK cell subsets depend-
ing on the expression of CD16 and CD56 molecules as regu-
latory (CD3−CD56+CD16−), cytotoxic (CD3−CD56+CD16+),
and defective (CD3−CD56−CD16+) (Figure 1C). Each of NK cell
subset was further analyzed for the frequency of cells expressing the
particular activating and inhibitory receptors and intensity of the
expression was estimated as geometric mean fluorescence intensity
(G-MFI) of gated positive population by using histogram analysis.
Figures 1D,E shows representative contour plot to demonstrate
discrimination between positive and negative population for the
presence of NK cell receptor (e.g., NKG2D)on NK cell subset from
RHI-HVL and LTNP respectively whereas Figure 1F represents
the histogram analysis of positive population used to determine
G-MFI.
FIGURE 1 | Gating strategy used to identify NK cells and the NK cell
subsets. Representative flowcytometry plots from the PBMCs of one of
the study participants. The lymphocytes were live gated during acquisition
using the side and forward scatter dot plot display (A). Furthermore, by
using the negative gating strategy, CD3-negative lymphocyte population
was identified (B). The NK cell population was further identified and
differentiated into regulatory (CD3−CD16−CD56+), cytotoxic
(CD3−CD16+CD56+), and defective (CD3−CD16+CD56−) NK cell subsets
on the basis of the expression of CD56 and CD16 (C). Representative
contour plot to demonstrate discrimination between positive and negative
population for the presence of NK cell receptor (NKG2D) (RHI-HVL) (D).
Representative contour plot to demonstrate discrimination between
positive and negative population for the presence of NK cell receptor
(NKG2D) (LTNP) (E). Representative histogram of positive population to
denote histogram analysis of each of the NK cell subset to determine
G-MFI of NK cell receptors (NKG2D) (F).
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CYTOTOXICITY OF NK CELLS
The cytotoxic potential of NK cells from the study participants
was assessed using total cytotoxicity and apoptosis kit (Immuno-
chemistry Technologies, Bloomington, MN, USA) as per the man-
ufacturer’s instructions. Briefly, PBMCs were co-cultured for 4-h
at 37°C with CFSE stained K562 cells at a 25:1 effector to tar-
get cells ratio in 500µl of RPMI medium with 10% FCS. The
cells were then stained by Sulforhodamine-Fluorochrome labeled
Inhibitor of Caspases (SR-FLICA) and were incubated for 45 min
at 37°C in humidified 5% CO2 incubator. The viability stain was
then added to co-cultured cell population of effector and target
cells. The cells were acquired on the flowcytometers (FACSCal-
ibur, Becton Dickinson, USA) within 30 min of staining and while
acquiring, the large sized K562 cells (target cells) were identified
using forward and side scatter (Figure 2A). The CFSE stained
K562 cells were further identified using a dot plot of CFSE vs.
Side scatter (Figure 2B). Fifty thousand gated events of CFSE
stained K562 cell were recorded and further analyzed for necrotic
(SR-FLICA−7AAD+), late apoptotic (SR-FLICA+7AAD+), and
early apoptotic (SR-FLICA+7AAD−) populations (Figure 2D).
The sum of percentages of these three types of population was con-
sidered as total cytotoxicity. Only target cells (CFSE stained K562
cells) were used as negative control (Figure 2C) whereas camp-
tothecin (3µg/ml) (Immunochemistry Technologies, Blooming-
ton, MN, USA) mediated apoptosis induced K562 cells were used
as positive control. Spontaneous killing of K562 cells was sub-
tracted from cytotoxic percentage obtained for the sample to
obtain the net cytotoxicity percentage. The formula used for
cytotoxicity assessment was as follows.
Cytotoxic potency= (% early apoptotic K562 cells+% late
apoptotic K562 cells+% Necrotic K562 cells)−% of K562 cells
undergoing spontaneous apoptosis (assessed in negative control).
STATISTICAL ANALYSIS
Digital data of scatter plots from the flow cytometer were ana-
lyzed with Flow Jo 7.6 software (Tree Star, Ashland, OR, USA). NK
cell frequencies and G-MFI of different receptors were compared
between the study groups using the non-parametric Mann–
Whitney U-test whereas the Spearman correlation was used to
assess the correlation between the plasma VL set point, cytotoxicity
FIGURE 2 |The scatter plots showing the gating strategy used to
distinguish necrotic, late apoptotic, and early apoptotic K562cells
(target) co-cultured with PBMCs as a source of NK cells (effector cells).
(A) Identification of large sized K562 cells using the FSC and SSC parameter.
(B) Detection of CFSE stained K562 cells. (C) Estimation of spontaneous lysis
of K562 cells: (Negative control): CFSE stained K562 cells alone incubated for
4 h. (D) Lysis of CFSE stained K562 cells by the effector cells: 7AAD X axis)
vs. SR-FLICA (Y axis) showing necrotic (7AAD+SR-FLICA−: upper left
quadrant), late apoptotic (7AAD+ SR-FLICA+: upper right quadrant), and early
apoptotic cells (7AAD− SR-FLICA+: lower right quadrant).
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potential of the NK cells and the expression of various receptors.
P < 0.05 was considered as significant. Graph Pad Prism (version
5.00, CA, USA) Software was used for analysis.
RESULTS
FREQUENCY OF NK CELLS AND SUBSETS IN PATIENTS WITH RECENT
HIV INFECTION
The median frequency (percentages) of NK cells and the interquar-
tile ranges (IQR) are summarized in Table 2. HIV infected
patients {patients with RHI [RHI-LVL (Median: 9.6%), RHI-HVL
(Median: 7.7%)], and progressors (Median: 4.5%) (p< 0.0001 in
all cases)} showed lower percentage of NK cells as compared to
those from the HC (Median: 15.8%) except the LTNPs (Median:
16.5%, p= 0.5). Further, NK cell frequency in patients with RHI
having high viral load set point (RHI-HVL) was found to be signif-
icantly lower as compared to RHI-LVL group (p= 0.011) and but
similar with the NK cells frequency seen in progressors (p= 0.16)
(Figure 3A).
Table 2 | Frequency of NK cells and subset wise distribution.
RHI-LVL RHI-HVL LTNP Progressors Healthy controls
Total NK cells (%) Median 9.6 7.8 16.5 4.51 15.8
IQR 8.9–11.2 7.2–8.2 13.3–19.2 2.7–8.8 13.3–18
Cytotoxic NK cells (%) Median 43.7 26.7 74.1 31 72.1
IQR 38.3–49.7 22.7–33.6 69.3–78.6 8–42.6 64.6–76.6
Regulatory NK cells (%) Median 15.5 5.9 17.7 8.8 16.1
IQR 11.5–19 2.9–14.5 11–23 6–20 13–22
Defective NK cells (%) Median 37.4 64 7.1 57.3 10.9
IQR 31.3–46.8 56.3–73.3 3.4–13.2 44.5–78.5 5.5–14
FIGURE 3 |Total NK cell frequency and subset wise distribution in study participants. (A) Total NK cell %, (B) cytotoxic NK cell %, (C) regulatory NK cell
%, and (D) defective NK cell %. *p<0.05, **p<0.01, ***p<0.001, and NS, not significant.
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NK CELL SUBSETS IN RECENT HIV INFECTION
Cytotoxic NK cells (CD3−CD56+CD16+) is a major NK cell sub-
set responsible for cytolysis of virally infected cells. As compared
to HC (median: 72.1%), the frequency of these cells was also sig-
nificantly lower in all study groups (p< 0.0001 in all cases) except
LTNPs (median: 74.1%, p= 0.459). The frequencies were similar
in RHI-HVL group (Median: 26.7%) and progressors (Median:
31%) (p= 0.84) (Figure 3B). The percentages of cytotoxic NK
cells was found to be associated positively with the CD4 counts
in early as well as late HIV-1 infection (r = 0.502, p= 0.002)
(Figure 4).
The frequency of regulatory NK cell subset (CD3−CD56
+CD16−), having cytokine secretion as the major function was
observed to be reduced in RHI-HVL group (Median: 5.9%)
(p= 0.01) and progressors (Median: 8.8%) (p= 0.04) as com-
pared to HC. Whereas the percentages of regulatory NK cell
were comparable among the LTNPs (Median: 17.7%) (p= 0.87),
RHI-LVL (Median: 15.5%), and HC (Median: 16.1%) (Figure 3C).
Significantly higher expansion of defective NK cells
(CD3−CD56−CD16+) was observed in recent HIV-1 infection
and progressors (Median: 57.3%) as compared to HC (Median:
10.9%) and LTNPs (Median: 7.1%) (p< 0.0001 in all cases)
(Figure 3D). The expansion of defective NK cells was significantly
less in RHI-LVL group (Median: 37.4%) as compared to RHI-HVL
group (Median: 64%) (p= 0.001).
NK CELL RECEPTOR PROFILE
The median G-MFI and frequency of all receptors and IQR val-
ues has been summarized in Table 3. As compared to HC, the
expression of activatory receptors on cytotoxic NK cells but not
on regulatory or defective NK cells was found to be altered signif-
icantly. Hence, only the analysis of expression of various receptors
on cytotoxic NK cells is presented here.
Within the HIV infected study groups the frequency of
NKp44 expressing cytotoxic NK cells was comparable (p> 0.05),
which was significantly higher than observed in HC (p< 0.001).
The frequency of NKp46 and NKp30 expressing cytotoxic
FIGURE 4 | Association between CD4 cell count and cytotoxic NK cells.
The CD4 T cell counts of patients with recent HIV infection are plotted on X
axis and the percentage of cytotoxic NK cells was plotted onY axis.
NK cells was comparable among all study groups although it
showed a trend of higher number in RHI-LVL, LTNPs, and
HC. The percentage of NKG2D+ cytotoxic cells was higher in
LTNPs followed by HC and RHI-LVL. Whereas frequency of
NKG2A+ and NKG2C+ cytotoxic NK cells was comparable in
all study groups (Table 3). Frequency of Cytotoxic NK cells
with expression of early activation markers such as CD69 and
HLA-DR were found to be higher in LTNPs and RHI-LVL as
compared to RHI-HVL (p< 0.01) and progressor (p< 0.001)
groups.
The determination of G-MFI of various receptors showed that
the NKp44 expression was significant higher in both RHI-LVL
(p< 0.0001) and RHI-HVL (p= 0.001) group as compared to
HC. The NKp44 expression in progressors and RHI-HVL was
comparable (p= 0.50) (Figure 5A).
The NKp30 expression was comparable in case of LTNP, RHI-
LVL group, and HC (p> 0.3) whereas it was significantly reduced
in RHI-HVL group (p< 0.001) and progressors (p< 0.001) as
compared to HC (Figure 5A).
NKp46, a marker, which is exclusively expressed by the NK cells,
was also found to have a lower expression in RHI-HVL group
(p= 0.001) and progressors (p= 0.01) as compared to the con-
trols, whereas the expression was comparable among RHI-LVL
group, LTNPs, and controls (p> 0.05) (Figure 5A).
Additionally,we also assessed the expression of activating NKG2
family of receptors. The expression of NKG2D receptor on cyto-
toxic NK cells was found to be lower in RHI-HVL group and
in progressors as compared to the expression in the controls,
RHI-LVL group, and LTNPs (p< 0.005 in all cases) (Figure 5B).
However, the patients with low VL set point showed lower NKG2D
expression as compared to the LTNPs (p= 0.04).
One of the other NKG2 receptor; NKG2C showed lower expres-
sion on cytotoxic NK cells of RHI-HVL group and Progres-
sors as compared to LTNPs, controls, and RHI-LVL (p< 0.05)
(Figure 5B).
The third receptor from NKG2 family; an inhibitory NKG2A
receptor is known to form a heterodimer with CD94 in a similar
fashion like that of NKG2C. We found that G-MFI of NKG2A was
comparable in all study groups with HIV-1 infection. The median
G-MFI for NKG2A expression was higher in RHI-HVL as com-
pared to RHI-LVL group however the significance has not reached
(Table 3).
The activation status of NK cells was determined by measur-
ing the expression of early activation markers such as HLA-DR
and CD69. Only the cytotoxic NK cells from LTNPs and RHI-
LVL group showed elevated expression of both HLA-DR and
CD69 as compared to RHI-HVL group and progressors (p< 0.01)
(Figure 5C) indicating presence of activated effector phenotype of
NK cells.
The higher expression of NKp46, NKp30, and NKG2D recep-
tors was found to be associated with low viral load set point
in RHI (Figures 6A–C) and with low viral load in case of
LTNPs and Progressors [NKp30 (r =−0.525, p= 0.01), NKG2D
(r =−0.826, p< 0.001), and NKp46 (r =−0.509, p= 0.01)].
Additionally the higher NKp46 and NKp30 expression was
also associated with higher CD4 count (r = 0.469, p= 0.02 and
r = 0.405, p= 0.007, respectively). Whereas higher expression of
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Table 3 | Frequency and expression level (G-MFI) of NK cell receptors.
RHI-LVL RHI-HVL LTNP Progressors Healthy controls
NATURAL CYTOTOXICITY RECEPTORS
NKp44 Frequency (%) Median 26.75 23.05 29.7 25.4 0.15
IQR 6.2–31.4 4.8–28.2 5–35.6 1.33–31.4 0.1–0.4
G-MFI Median 357 231.5 452.5 116 103
IQR 320–426 115–352 380–550 106–125 108–111
NKp30 Frequency (%) Median 46.68 40.505 52.15 43.27 55.5
IQR 19.1–51.7 13.6–65 27.6–70 15.6–60.4 23.2–83
G-MFI Median 324.5 218.5 458 256.5 382
IQR 240–355 142–348 414–567 228–303 222–376
NKp46 Frequency (%) Median 78.63 76.3 86.8 64.2 84
IQR 33.3–99 58.5–95.5 71.1–98.2 45.5–94.3 51.2–71.9
G-MFI Median 461 340.7 740 410 525
IQR 332–902 273–430 645–827 325–538 436–660
NKG2 FAMILY OF RECEPTORS
NKG2D Frequency (%) Median 89.85 44.6 74.11 45.5 64.56
IQR 69.9–94.3 24.6–58.7 43 –81.7 36.6–62.5 32.6–78.1
G-MFI Median 377 185 622 124 571
IQR 248–850 115–222 391–1237 165–184 416–917
NKG2C Frequency (%) Median 42.59 57 47.4 43.3 24.5
IQR 34.7–52 46.1–65.4 42.9–70.2 23.8–59.6 18.7–61
G-MFI Median 439.4 425.3 1117 465 798
IQR 245–593 318–508 709–3096 418–644 764–909
NKG2A Frequency (%) Median 27.2 34.7 35.3 24.9 9
IQR 21–41.7 27–43 27.2–55.4 12.78–42.5 4.53–11
G-MFI Median 486 598 460.5 444 814
IQR 258.2–587 382–656.6 335–1626 420–648 669.2–1330
EARLY ACTIVATION MARKERS
HLA-DR Frequency (%) Median 31.8 24.9 33.8 25.7 12.2
IQR 19.9–41.7 7.3–40.7 4.8–39.6 6.32–44.5 4.7–23.6
G-MFI Median 320 142 636 140 405
IQR 188–587 117–482 469–813 128–242 236–763
CD69 Frequency (%) Median 32.9 30.92 13.3 9.68 4.555
IQR 3.43–35.7 1.11–66 7.28–13.7 2.81–63.4 2.93–8
G-MFI Median 150 203 462.5 167 407.75
IQR 129.5–187 182.5–204 442–491.5 132–206 283.6–452.2
INHIBITORY RECEPTORS
CD158b Frequency (%) Median 51.3 56.2 40.1 47.5 19.9
IQR 43–62.3 50.2–59.1 27.6–51.4 19.1–54.8 10.3–26
G-MFI Median 478 458.5 1085 193 905
IQR 424.6–505 337.5–610 870–1178 152–278 708.5–1054.2
ILT2 Frequency (%) Median 31 24.95 33.05 28.2 2.75
IQR 9–39.9 4.4–34.8 13.6–56 8.21–35 1.62–8.2
G-MFI Median 127 136.5 1196 628.9 541
IQR 120–133.5 120–171.5 647–2664 326.7–647 509–958
NKG2A was associated with high viral load set point (r = 0.450,
p= 0.01) in RHI.
The inhibitory receptors such as CD158b, and ILT2 (CD85j)
were down regulated in all HIV-1 infected individuals except
LTNPs as compared to HC and none of the inhibitory receptors
showed any significant association either with viral load set point
or CD4 count (Table 3).
CYTOTOXICITY OF NK CELLS
We further wanted to assess whether the cytotoxic potential of NK
cells was compromised in RHI and whether it had any association
with viral multiplication. Overall, NK cells of patients with RHI
showed reduced cytotoxic potency as compared to the controls
and the potency was found to be reduced further in RHI-HVL
group (Median: 29.1, IQR: 22.4–37.6) as compared to RHI-LVL
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FIGURE 5 | Natural killer cell receptor profile of cytotoxic NK cells in HIV infection. (A) Natural cytotoxicity receptors (NKp44, NKp30, and NKp46),
(B) activating receptors: NKG2D and NKG2C, and (C) early activation receptors HLA-DR and CD69.
group (Median: 36.2, IQR: 32.2–41.2, p= 0.007). The Progressors
also showed reduced cytotoxicity (Median: 24.2, IQR: 19.1–26.5)
comparable to that seen in RHI-HVL group. The cytotoxicity was
comparable in LTNPs (Median: 48, IQR: 42.–51.2, p= 0.0017) and
HC (Median: 42.2, IQR:34–50.2, p= 0.005). NK cells from LTNPs
showed the maximum cytotoxic capacity (Figure 7A).
The NK cell cytotoxicity showed significant positive associ-
ation (r = 0.720; p= 0.001) (Figure 7B) with CD4 counts and
significant negative association with, viral load set point in recent
HIV-1 infection (r =−0.701; p= 0.0006) (Figure 7C). We also
found that low viral load values at enrollment visit in all HIV-1
infected patients were associated with higher cytotoxic potency
(r =−0.576; p= 0.001) (Figure 7D). The percentage of apop-
totic cells was also negatively associated with viral load set point
(r =−0.822; p< 0.0001) indicating that apoptosis could be the
major mechanism of early NK cell mediated lysis. As expected
higher, NK cell cytotoxicity was significantly associated with the
expression of NK cell activating receptors such as NKG2D, NKP46,
and NKp30.
DISCUSSION
The aim of the present study was to assess the expression pattern
of an array of activating and inhibitory receptors on NK cells in
early HIV infection and its potential role on virus control and
disease progression by using viral load set point as a surrogate
marker for disease progression. To understand the influence of
these receptors further in the course of the disease, the expression
and frequency of these receptors was assessed in LTNPs and Pro-
gressors. In concordance with other studies (5, 24, 25), the present
study also showed compromised NK cell frequency in early HIV
infection. However, the degree NK cell mutilation was significantly
lesser in patients with low viral load set point. The higher frequen-
cies of NK cells in LTNPs indicated that during the course of HIV
infection, maintenance of NK cell functionality was important to
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FIGURE 6 | Association of expression of activating receptors and viral
load set point. The G-MFI of NKp46 (A), NKp30 (B), and NKG2D (C) is
plotted onY axis and the log of viral load set point is shown on the X axis.
control virus multiplication and slowing down the disease progres-
sion. The higher percentages of cytotoxic and regulatory NK cells
in recently infected patients with low viral load set point indicated
the positive influence of early NK cell responses on the rate of HIV
disease progression. Since the NK cell frequencies were measured
before the setting of viral load set point in these patients, it may
be possible that the presence of adequate number of cytotoxic and
regulatory NK cells might be responsible for lysis of HIV infected
cells and decreasing viral multiplication thus setting the low viral
load set point. However the cause and effect relationship is difficult
to establish in this cross-sectional study. The significant associa-
tion of higher CD4 counts with higher percentage of cytotoxic NK
cells and their cytotoxic potential in the present study indicated
that NK cells might not be involved in non-specific CD4 lysis in
early HIV infection as it was suspected in earlier studies (26, 27).
The HIV infected CD4 T cells have been found to up regulate lig-
ands of NKG2D such as MICA, MICB, and ULBP2 (28). Hence,
this mechanism might be responsible for rendering the infected
cells susceptible to NKG2D-mediated NK cell lysis sparing the
uninfected ones. However due to scarcity of sample the expression
analysis of these ligands on CD4 cells was not possible.
We observed significantly higher expression of NKp44 in
patients with RHI as compared to HC indicating the activation
of cytotoxic NK cells in early HIV infection with further higher
expression in patients with low viral load set point. The expression
of NKp44 was comparable in LTNPs and patients with low viral
load set point. However, Marras et al. previously showed absence
of expression of NKp44 after IL-2 stimulation in vitro in case of
the Elite controllers/LTNPs (27). It might be possible that the HIV
gp41 mediated increased expression of NKp44 ligands on infected
cells have made the infected cells susceptible to NKp44 mediated
lysis. It has been indeed shown that the HIV antigens such as
gp41 up regulate ligands of NKp44 on infected cells (17). This
could be another reason for preserving the uninfected CD4 cells
in the present study. It will be interesting to assess the presence and
functionality of the anti-gp41 antibodies in this study population.
Higher expression of natural cytotoxicity receptors was found
to be linked with low viremia. NKp30 plays a major role in NK
cell activation, degranulation, and cytotoxicity (29) and also in
maturation of dendritic Cells (DCs) to stimulate T-cell responses
(30). Hence, it could be possible that the higher NKp30 expression
in RHI-LVL group and LTNPs might have driven the efficient DC
function to generate adequate T-cell response in early HIV infec-
tion and in LTNPs. Indeed, we have observed higher frequency of
Gag-specific polyclonal CD8 responses in the RHI-LVL group as
compared to RHI-HVL group (Unpublished data).
In addition to NKp44 and NKp30, NKp46 expression was also
higher in RHI-LVL group as compared to RHI-HVL group. It has
been observed that the cytolytic potential of cytotoxic NK cells
expressing NKp46, NKp30, and NKp44 decreased with disease
progression (31) whereas in treatment interruption, expression of
NKp46 was found to be reduced (32). It is likely that higher NCR
expression in patients with low viral load set point was responsi-
ble for early virus control resulting in slow/no disease progression.
Additionally, the maintenance of optimal NCRs might be required
for the continued viral control during HIV infection as evident
from the higher NKp46 expression in LTNPs.
Expression of NKG2D, an activating receptor was found to be
higher in RHI-LVL group and LTNPs as compared to RHI-HVL
group and progressors. NKG2D is an activating receptor found
on NK cells and CD8+ T cells. It binds to the ligands expressed
by the cancerous or infected cells or to the soluble form of lig-
ands released by these cells (14). Viruses, including HIV have been
shown to induce the expression of stress ligands for NKG2D (13)
on infected cells. However, Nolting et al. showed that chronic HIV-
1 infection is associated with reduced NKG2D expression resulting
in specific defect in NKG2D-mediated NK cell activation (33).
Hence, NKG2D has been thought to be important in viral control
in HIV (14). Also it has been shown that TGF-beta down-regulates
the expression of NKp30 and NKG2D (34) and increased TGF-beta
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FIGURE 7 | Cytotoxic potency of NK cells in study participants. The
vertical scatter plot shows the percentages of lysed target cells (Y axis) as a
measure of cytotoxic potency of the NK cells from all the study groups (X
axis). LTNPs showed highest cytotoxic potency (Dots are highlighted by gray
color) (A). Association of cytotoxic potency of NK cells (X axis) with the
markers of disease progression on y axis; the CD4 count (B) and the plasma
viral load set point (C) and viral load at enrollment visit in HIV-1 infected study
participants (D).
production by PBMCs has been shown to be induced by HIV-1 tat
and env (35–38). Thus, it might be possible that the higher viral
replication induced TGF-β secretion by HIV infected CD4 cells.
This increased TGF-β secretion could be responsible for decreased
expression of NKp30 and NKG2D on NK cells in the RHI-HVL
group. It would be interesting to study the role of TGF-β secretion
in NKp30 expression and cytotoxicity of NK cells.
We also observed higher expression of NCRs and NKG2D in
LTNPs as compared to HC as well, which indicates that constitu-
tive higher NCR and NKG2D expression may be able to keep HIV
at bay after acquisition.
All these findings collectively indicate that optimal and sus-
tained expression of activating receptor might be essential for virus
control in early HIV infection and thus slowing down disease pro-
gression. The study also showed higher expression of HLA-DR and
CD69 receptors in RHI-LVL group and LTNPs indicating that the
mature activating stage of cytotoxic NK cells might have positive
influence on the virus multiplication.
We further assessed showed that cytotoxic potential of the NK
cells was associated with lower plasma viral load set point and
higher CD4 counts indicating the probable important role of
cytotoxicity in early virus control. The HIV infected CD4 T cells
have been found to up regulate ligands of NKG2D such as MICA,
MICB, and ULBP2 (28). Hence, we speculate that this mecha-
nism might be liable for making the infected cells susceptible to
NKG2D-mediated NK cell lysis and sparing the uninfected one. We
could not use the autologous HIV-1 infected CD4 cells to assess
cytotoxic potency due to paucity of cryopreserved PBMCs. Hence,
K562 cells were used as target cells to analyze cytotoxic potency as
a proxy marker for cytolysis of HIV infected autologous CD4 cells.
Indeed, a study by Fogli et al. found that the ability of NK cells
from HIV-1 infected viremic patients to lyse K562 and autologous
p24+ CD4 blast was comparable (39).
A study in CAPRISA cohort have shown that the participants
having NK cells with impaired IFN-γ secretion were prone to
acquire HIV infection (40). Our study has further observed that
after acquiring HIV infection, the patients having cytotoxic NK
cells with higher expression of activating receptors such as NKp44,
NKp46, NKp30, and NKG2D could be efficient killers of virally
infected cells in the early course of HIV infection. Patients with
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low viral load set point have been shown to have slow disease pro-
gression (41). Although this was a cross-sectional study, higher
expression of the activating receptors on NK cells in LTNPs and
lower expression in Progressors highlight the importance of the
maintenance of expression of these receptor in keeping the virus
multiplication under control resulting in delayed or no disease
progression. Hence, development/maintenance of potent cyto-
toxic NK cells could be one of the important treatment/prevention
strategies.
Although, the small sample size of the patients with RHI and
cross-sectional design of the study were the limitations, the study
has signified the potential role of constitutive expression of acti-
vating receptors on cytotoxic NK cells in viral control in early HIV
infection. The study to identify the influence of HIV on the molec-
ular mechanism of the expression of these receptors will be helpful
in further understanding of NK cell mediated control in early HIV
infection.
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